跳至主要内容
临床试验/CTRI/2020/02/023194
CTRI/2020/02/023194已完成未知

A Prospective Study to Evaluate the Safety and Efficacy of Levetiracetam in Comparison To Magnesium Sulphate in the Management of Severe Pre â?? Eclampsia and Imminent Eclampsia. - SELCOMSUPE

BLDE Deemed to be University0 个研究点目标入组 30 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.All pregnant women with gestational age above 28 weeks presenting with features of severe pre eclampsia and imminent eclampsia during the period will be recruited into the study
  • 2.Patients giving informed and written consent for investigations

排除标准

  • 1.Patients who were diagnosed with other causes of convulsions in pregnancy like cerebral malaria and epilepsy
  • 2.Chronic hypertensive pregnant females
  • 3.Pregnant females with fetal anomalies detected on USG
  • 4.Patients who withdraw the consent for further participation in the study

研究者

发起方
BLDE Deemed to be University

相似试验

Study to Evaluate the Safety and Efficacy of... | 临床试验